Hanp


Combined with:

Lasix

Indications and Reactions:

Role Indications Reactions
Secondary
Cardiac Failure Chronic 12.7%
Hypertension 12.3%
Cardiac Failure 10.1%
Mineral Supplementation 6.3%
Obstruction Gastric 6.0%
Insomnia 5.6%
Iron Deficiency Anaemia 5.6%
Diarrhoea 4.5%
Tachycardia 4.1%
Anaesthesia 3.7%
Blood Pressure Management 3.4%
Prophylaxis Against Gastrointestinal Ulcer 3.4%
Asthma 3.0%
Basedow's Disease 3.0%
Endotracheal Intubation 3.0%
Infection Prophylaxis 3.0%
Steroid Therapy 3.0%
Coagulopathy 2.6%
Hyperuricaemia 2.6%
Drug Use For Unknown Indication 2.2%
Thrombocytopenia 18.5%
Multi-organ Failure 14.8%
Platelet Count Decreased 14.8%
Hypotension 7.4%
Viral Myocarditis 7.4%
White Blood Cell Count Increased 7.4%
Blood Pressure Systolic Increased 3.7%
Interstitial Lung Disease 3.7%
Ischaemic Hepatitis 3.7%
Oliguria 3.7%
Shock 3.7%
Sinus Arrhythmia 3.7%
Thirst 3.7%
Urine Output Decreased 3.7%
Concomitant
Cardiac Failure 13.6%
Prophylaxis 11.2%
Sedation 8.8%
Fluid Replacement 7.6%
Product Used For Unknown Indication 7.4%
Hypertension 6.4%
Infection 6.2%
Acute Myocardial Infarction 4.0%
Infection Prophylaxis 3.9%
Drug Use For Unknown Indication 3.9%
Ureteral Stent Insertion 3.3%
Ureteral Stent Removal 3.3%
Insomnia 3.3%
Pyrexia 3.2%
Pneumonia 2.8%
Diuretic Therapy 2.7%
Diabetes Mellitus 2.4%
Ventricular Tachycardia 2.2%
Electrolyte Substitution Therapy 2.1%
Angina Pectoris 1.8%
Renal Impairment 11.8%
Respiratory Failure 10.4%
Multi-organ Failure 7.1%
Renal Failure 6.1%
Rhabdomyolysis 5.7%
Sepsis 4.7%
Death 4.2%
Pneumothorax 4.2%
Thirst 4.2%
Toxic Epidermal Necrolysis 4.2%
Urine Output Decreased 4.2%
White Blood Cell Count Decreased 4.2%
White Blood Cell Count Increased 4.2%
Cardiac Failure 3.8%
Interstitial Lung Disease 3.8%
Pyrexia 3.8%
Hypernatraemia 3.3%
Platelet Count Decreased 3.3%
Renal Failure Acute 3.3%
Ventricular Tachycardia 3.3%

Drug Data